Exemestane, Clinical Relevance
jurnal doxorubicin
Breast lump (nandinii)
Efficacy endpoints in Oncology
ASCOs eighth annual Clinical Cancer Advances report identifies this years most significant clinical cancer advances Highlights 17 most important advances,
Strategia terapeutica nella malattia avanzata Claudia Bighin Istituto Nazionale per la Ricerca sul Cancro Genova Roma, 19 Febbraio 2005.
1 Management of Breast Cancer By Hussein M. Khaled Prof. Medical Oncology Vice President Post graduate Studies and Research Cairo University.
Progress Against Breast Cancer. 1970–1979 Progress Against Breast Cancer 1970–1979 1971: More limited mastectomy proven effective for early-stage breast.
Textural Analysis as a Predictor of Breast Tumour Response to Neoadjuvant Chemotherapy P Gibbs, M Lowry, and LW Turnbull Centre for MR Investigations,
Breast cancer clinical pathway: are doctors aware? Ana Filipa Amador | Ana Rita Comba | Bárbara Castro | Beatriz Ferreira | Daniela Casanova | Duarte Alves.
Results of Two Open Label Multicenter Phase II Pilot Studies (BCIRG 101 and 102) with Trastuzumab (Herceptin ® ) in Combination with Docetaxel and Platinum.
Background and Controversies in Dosing and Adjustment of Chemotherapy Agents Dana Cole, BScPharm, PharmD Oncology Drug Information Specialist BC Cancer.